600422.SS · 昆药集团
China A-shares · RS rating 37 · As of 2026-10-14
| Price | 8.49 CNY |
|---|---|
| 1-day change | +1.8% |
| RS rating (overall / 1M / 3M / 12M) | 37 / 78 / 61 / 13 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 20 / 11 / 20 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -3.5% |
| Distance from 52-week high | +40.4% |
| Market cap (USD) | $926.0M |